Cargando…
Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes
More than 500 million adults suffer from diabetes worldwide, and this number is constantly increasing. Diabetes causes 5 million deaths per year and huge healthcare costs per year. β-cell death is the major cause of type 1 diabetes. β-cell secretory dysfunction plays a key role in the development of...
Autores principales: | Dalle, Stéphane, Abderrahmani, Amar, Renard, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050720/ https://www.ncbi.nlm.nih.gov/pubmed/37008937 http://dx.doi.org/10.3389/fendo.2023.1076343 |
Ejemplares similares
-
Compensatory Mechanisms of Pancreatic Beta Cells: Insights into the Therapeutic Perspectives for Diabetes
por: Regazzi, Romano, et al.
Publicado: (2014) -
Decompensation of β-Cells in Diabetes: When Pancreatic β-Cells Are on ICE(R)
por: Salvi, Roberto, et al.
Publicado: (2014) -
Editorial: Cellular dysfunction and death in diabetes (etio)pathology: Novel insights into molecular mechanisms and therapeutic targeting
por: Markelic, M., et al.
Publicado: (2023) -
Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?
por: Lodato, Michele, et al.
Publicado: (2023) -
Editorial: Understanding the gene expression of β cell dysfunction in diabetes
por: Sjöholm, Åke, et al.
Publicado: (2022)